Stmnt re Share Price Movement

Oxford Biomedica PLC
19 January 2005




NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF
AMERICA, CANADA, AUSTRALIA OR JAPAN


Oxford BioMedica plc ('Oxford BioMedica' or the 'Company')

Response to share price movement

The Board of Oxford BioMedica notes the recent movement in the Company's share
price.  The Board confirms that it has received an approach from a third party
and that it is in discussions regarding a potential merger.

The Board wishes to stress that discussions are at an early stage and may or may
not lead to an offer for the Company.

19 January 2005


Enquiries:
Oxford BioMedica plc                                    Tel: [phone]
Professor Alan Kingsman, Chief Executive Officer
Andrew Wood, Chief Financial Officer






                      This information is provided by RNS
            The company news service from the London Stock Exchange